Sindbis virus is composed of two nested T = 4 icosahedral protein shells containing 240 copies each of three structural proteins: E1, E2, and Capsid in a 1:1:1 stoichiometric ratio. E2 is a 423 amino acid glycoprotein with a membrane spanning domain 26 amino acids in length and a 33 amino acid cytoplasmic endodomain. The interaction of the endodomain with the nucleocapsid is an essential step in virus maturation and directs the formation of the outer protein shell as envelopment occurs. A previous study had determined that deletions in the transmembrane domain could affect virus assembly and infectivity (Hernandez et al., 2003. J. Virol. 77 (23), 12710 -12719). Unexpectedly, a single deletion mutant (from 26 to 25 amino acids) resulted in a 1000-fold decrease in infectious virus production while another deletion of eight amino acids had no affect on infectious virus production. To further investigate the importance of these mutants, other single deletion mutants and another eight amino acid deletion mutant were constructed. We found that deletions located closer to the cytoplasmic (inner leaflet) of the membrane bilayer had a more detrimental effect on virus assembly and infectivity than those located closer to the luminal (outer leaflet) of the membrane bilayer. We also found that selective pressure can restore single amino acid deletions in the transmembrane domain but not necessarily to the wild type sequence. The partial restoration of an eight amino acid deletion (from 18 to 22 amino acids) also partially restored infectious virus production. The amount of infectious virus produced by this revertant was equivalent to that produced for the four amino acid deletion produced by site directed mutagenesis. These results suggest that the position of the deletion and the length of the C terminal region of the E2 transmembrane domain is vital for normal virus production. Deletion mutants resulting in decreased infectivity produce particles that appear to be processed and transported correctly suggesting a role involved in virus entry. D
Introduction
Sindbis virus (SV) is an alphavirus, which is propagated in nature via a complicated life cycle involving insect vectors and mammalian hosts. Mature SV contains 240 copies each of three structural proteins E1, E2, and Capsid (C) in a 1:1:1 stoichiometric ratio. These proteins are organized into two geometrically identical T = 4 icosahedral shells (Paredes et al., 1993) . The outer protein shell is composed of the E1 and E2 glycoproteins organized in trimers of heterodimers (Anthony and Brown, 1991; Carleton et al., 1997; Pletnev et al., 2001 ). This outer shell surrounds the inner shell, composed of protein C, which is assembled around the viral RNA. A host-derived membrane bilayer is positioned between the two shells and is penetrated by the transmembrane (TM) domain anchors of E1 and E2 (Lilijestrom and Garoff, 1991; Rice et al., 1982; Strauss et al., 2002) .
SV structural proteins are produced from a subgenomic mRNA which encodes a polypeptide that is posttranslationally cleaved into capsid, E1, E2, E3, and 6K. The capsid protein is removed by auto-proteolysis after translation on cytoplasmic ribosomes. Removal of capsid exposes a signal sequence at the amino terminus of the developing polypeptide. This sequence directs the translational complex to the endoplasmic reticulum where the envelope glycoproteins are synthesized. Synthesis on the ER results in the incorporation of the protein as a multipass membrane protein with six membrane-spanning domains (Lilijestrom and Garoff, 1991 ) (see Fig. 1 ). The polyprotein is processed into PE2, 6K, and E1 by signal peptidase (Lilijestrom and Garoff, 1991) . Transmembrane domain five of the 6K protein plays a role in the correct integration of E1 into the membrane (Lilijestrom and Garoff, 1991) . The 6K protein, which contains transmembrane domains four and five, is released by signal peptidase and is only found at very low levels in mature virus (Gaedigk-Nitschko and Schlesinger, 1990) . Prior to export to the cell surface, the E1 glycoprotein is folded into a stable compact high-energy conformation as it is assembled into heterotrimers with PE2 (Carleton et al., 1997; Mulvey and Brown, 1994 , 1995 . En route to the cell surface, PE2 is processed to E2 and E3 by the furin protease, which resides in the trans-Golgi network, (Moehring et al., 1993) and E1 is converted from a stable to a metastable configuration. E3, which contains transmembrane domain one, is not present in the mature virus. During transport of the trimeric complexes to the plasma membrane, the second membranespanning region of E2 (see Fig. 1 , domain 3) is retracted from the membrane and the 33 amino acid endodomain is exposed to the cytoplasm. The E2 endodomain specifically interacts with a hydrophobic cleft in the capsid protein Lee et al., 1996; Oates et al., 1992; Kuhn, 1996, 1997) . The interaction between E2 and C gives stability to the structure of the virus and plays a critical role in the formation of the outer virus protein shell around the preformed inner protein shell as the process of envelopment takes place . At the plasma membrane, the E1 -E2 heterotrimers are recruited into the outer protein shell by association of the E2 endodomain with the icosahedral nucleocapsid (Owen and Kuhn, 1997) .
In mature SV, only transmembrane regions two (E2) and six (E1) remain membrane associated (see Fig. 1 ). The amino acid sequences of the transmembrane regions are not conserved among the alphaviruses, however the hydrophobic nature and approximate length (26 -28 amino acids) are conserved. Previously, sequential deletions were made in the E2 transmembrane domain to investigate the interaction of the 26 amino acid membrane-spanning domain with the membrane bilayer. Deletion of a single methionine at position 379 (TM25) resulted in a 3 to 4 log loss in production of infectious virus . Many different factors could contribute to the observed phenotype of the TM25 mutant. (i) The observed phenotype could be a result of a single specific amino acid deletion at position 379. (ii) The angular location of the deletion on the face of the transmembrane helix may account for the loss of infectivity (i.e., if the deletion is made 90 degrees, 180 degrees or another angle from a set point of reference). (iii) The location of the deletion vertically (i.e., closer to the luminal side or closer to the cytoplasmic side of the membrane) may contribute to the observed phenotype. (iv) A specific interaction between the E1 and E2 transmembrane regions may be necessary for normal virus infectivity and this interaction may be impaired by the mutation. Strauss et al. (2002) have demonstrated an interaction between E1 and E2 transmembrane domains using a chimeric virus composed of Ross River E1 and Sindbis virus E2.
To further characterize the E2 membrane-spanning domain and investigate the importance of the factors presented above, additional single deletion mutants and an eight amino acid deletion mutant were constructed in the E2 transmembrane domain. Mutant sites were chosen to encompass all faces of the helix and to traverse the helix from the N terminus to the C terminus within the E2 transmembrane domain. It was found that deletions located closer to the cytoplasmic face of the membrane region resulted in a greater loss of infectivity than deletions located closer to the lumenal side of the membrane. Also deletions located on one face of the helix and close to the cytoplasmic interface resulted in reduced infectious virus production. The results presented herein suggest (i) the observed phenotype of the TM25 mutants is not due to a single specific amino acid deletion, (ii) the location of the deletion vertically is important for normal virus growth, (iii) the angular location of the deletion on the face of the helix does not affect normal virus growth and (iv) an interaction may be occurring between the E1 and E2 transmembrane domains in the cytoplasmic half of the transmembrane domain. In addition, other factors may influence the observed phenotype. The membrane composition differs from the inner leaflet to the outer leaflet of the membrane (Stoffel et al., 1975) . Also, deletions within the transmembrane domain may have a long range effect on the interaction between the E2 endodomain and the capsid protein.
Results

Virus production by Sindbis virus E2 single amino acid (TM25) mutants
Transmembrane domain two (see Fig. 1 ) was chosen for mutagenesis because of E2's interaction with both the inner and outer icosahedral protein shells . Previously, a series of sequential deletions in the E2 transmembrane domain were produced . The goal of these experiments was to elucidate the requirements placed on the length of the transmembrane domain for integration into cell Fig. 1 . A schematic representation of the organization of the Sindbis virus structural proteins in the membrane of the endoplasmic reticulum. The integrated polyprotein has six transmembrane domains labeled 1 to 6. The 6K protein is eliminated from the developing spike complex after processing by signal peptidase. The N-terminal region of PE2 is removed in the Golgi by Furin protease. Of the remaining three domains that are incorporated into virus, domain 3 is withdrawn from the membrane and attaches to nucleocapsids. Domains 2 and 6 are membrane anchors.
membranes and for assembly of infectious virus. In that study, a single deletion of a methionine at position 379 yielded a decrease in infectious virus production of four orders of magnitude . The relative infectivity of this mutant measured as the particle/pfu ratio was approximately 10 5 suggesting that virus assembly occurred, but that the resulting virus population was largely noninfectious. To further determine the effect of single deletion mutations in the transmembrane domain on virus assembly and infectivity, a series of single amino acid deletions were produced in the E2 transmembrane domain (Fig. 2 ). Deletions were placed at positions ranging from the luminal to the cytoplasmic side of the membrane bilayers. In addition, the deletions also covered all faces of the transmembrane helix (Fig. 2) .
Virus production by these mutants in BHK cells is shown in Fig. 3A . The data show that the wild-type virus, SVHR, yields a titer of approximately 10 9 pfu/ml. The single amino acid deletion mutants DM379, DA385, and DV386 all gave reduced titers of approximately 10 6 pfu/ml. Mutants DA370, DV371, DA372, DS373, and DV376 produced relatively higher titers of approximately 10 8 pfu/ml but still an order of magnitude below wild type. Single deletion mutants located in the N terminal region of the E2 transmembrane domain produced two logs more infectious virus than those located in the C terminal region of the transmembrane domain. The difference in infectious virus production from mutants in the N terminal and the C terminal TM region did not represent a gradual decline but a two-log decrease that occurred between positions 376 and 379. This suggests that single deletion mutations located closer to the N terminal portion of the transmembrane domain have a less detrimental effect than those located closer to the C terminal domain. These domains are separated by as few as three amino acids.
Affect of transmembrane domain length on virus infectivity
We have described a mutant, FF391/392 (FF), which inserts an extra amino acid into the E2 glycoprotein at the interface of the cytoplasmic side of the membrane bilayers (Hernandez Relative infectivity of the TM25, TM18, FF and FF25 mutants as determined by particle-to-pfu assay. Virus utilized in this experiment was released from the cell into the media and purified (see Methods). Mutant virus particles banded to wt density. Those mutants producing higher titers had lower particle-to-pfu ratios indicating more of the particles produced from these mutants were infectious, with the exception of the FF mutant. Except for FF, the mutants produce similar amounts of particles. , 2005) . This insertion results in a 3000-fold loss of infectious virus production in BHK cells. This mutant was utilized as the parent into which the deletion at M379 was placed to determine if infectious virus production could be rescued by restoring the wild-type number of amino acids to the carboxyl terminal end of E2. These two mutants (FF and DM379) have one extra or one fewer amino acid, respectively, in the C terminal domain of E2 and both yield reduced production of infectious virus. The resulting mutant was designated TM25(DM379)FF391/392, (abbreviated to FF25) and results in the restoration of a wt number of amino acids in the COOH region of E2. The parent FF mutant produced a titer of approximately 10 6 pfu/ml, whereas the FF25 mutant produced a titer of approximately 10 8 pfu/ml (Fig. 3A ). When these two mutations (FF and DM379) are combined the wt number of amino acids is restored and the level of infectious virus production is rescued. A critical number of amino acids may be required in the C terminal region of E2 for interaction with E1 or with the capsid protein.
Virus production of Sindbis virus containing large E2 TM deletions
We have previously shown that a deletion of eight amino acids (TM18) in the N terminal region of the E2 transmembrane domain results in normal virus production . This very puzzling observation raised a number of questions regarding the role of the TM domain in virus assembly and infectivity. For example; why does Sindbis virus have 26 amino acids in the TM domain if only 18 will suffice for normal virus production? The data presented above show that single deletions in the E2 TM domain have a significantly less deleterious effect if they are located in the region of the TM domain where the original TM 18 deletion was produced (amino acids 372-379). To further investigate the finding that mutations located closer to the C terminal end of the transmembrane had a greater effect on virus production than those located closer to the N terminal end two TM18 mutants were studied (Fig. 2) , the original eight amino acid N terminal deletion of residues 372-379 (TM18N) and a C terminal deletion of residues 379 -386 (TM18C). Three of the single deletion mutants yielding a titer of 10 8 pfu/ml (DA372, DS373, and DV376) were located in the N terminal sequence included in the TM18N deletion and the single deletion mutants yielding a titer of 10 6 pfu/ml (DM379, DA385, and DV386) were all located in the C terminal sequence included in TM18C deletion. TM18N produced similar levels of infectious virus as wild type (10 9 pfu/ml) (Fig. 3A) , whereas, TM18C produced greatly reduced levels of infectious virus (10 4 pfu/ml). Similar results were found when TM18N and TM18C were transfected into an insect cell line (Aedes albopictus clone U4.4). In insect cells TM18C and TM18N yielded a titer of 7.3 Â 10 3 and 7.0 Â 10 9 pfu/ml, respectively. Taken together, these data demonstrate that the N terminal region of the E2 transmembrane domain is not as essential for normal virus growth in BHK-21 or U4.4 cells as is the C terminal region.
Relative infectivity of the E2 TM deletion mutants
Equal volumes of virus released from the cell by the various TM mutants were purified by equilibrium density gradient centrifugation on linear potassium tartrate gradients as described in Materials and methods. All of the TM mutants were found to produce virus that banded at a mean density of 1.20 gm/cm 3 indicating that they are similar in composition to wild type virus in that they contain a normal complement of protein, lipid, and RNA.
The relative infectivity (particle-to-PFU ratio) of the TM deletion mutants was determined as described in Materials and methods. Particle-to-PFU it is a measure of total viral particles to infectious particles which were released into the cell supernatant. For example, if a mutant has a particle/pfu in 10, then 1 in 10 viral particles released from the cell is infectious. The results are shown in Fig. 3B . The profile of particle-to-PFU ratio for the TM25 mutants is approximately the inverse of the virus production profile shown in Fig. 3A . All of the TM25 mutants produce similar amounts of virus particles (within 1 log), but the relative infectivity of these viruses differ greatly. Deletion mutants DA370, DV371, DA372, DS373, and DV376 yield lower particle/pfu ratios and thus produce virus with a relatively high infectivity. Deletion mutants DM379, DA385, and DV386 all give higher particle/pfu ratios and thus have a relatively lower infectivity.
The FF and FF25 mutants produced particle/pfu ratios of 1.2 Â 10 3 and 2.8 Â 10 4 , respectively. In comparison to DM379, DA385, and DV386 vastly more of the particles produced by FF and FF25 were infectious. This result suggests that the loss of infectious virus production for FF may be due to the inability of this mutant to correctly assemble virus particles (Hernandez et al., 2005) .
Deletion mutations TM18C and TM18N have particle/pfu ratios of 9.6 Â 10 8 to 1 and 4.5 Â 10 1 to 1, respectively (Fig.  3B ). This demonstrates a large number of particles are produced for TM18C, however, only a very small amount of the particles assembled are infectious in comparison to TM18N.
SDS-PAGE analysis of purified virus particles produced the same protein banding pattern and ratio of incorporated proteins as wt (Table 1 ). These data indicate that the high particle to PFU ratios obtained for the DM379, DA385, and DV386 mutants are not the result of a failure to incorporate normal amounts of protein into the virus particles. These data could not be obtained for the TM18C mutant due to the very low yield of virus produced. Electron microscopy of negatively stained preparations of the DM379, DA385, DV386, and TM18C mutants revealed virus that was morphologically similar to wt (data not shown). The particle/pfu data support these conclusions in that the density of the mutant virus particles is similar to wt density suggesting a normal complement of protein, lipid, and RNA. If an altered particle to PFU ratio was due to failure to incorporate structural proteins in normal ratios the density of the virus produced would be expected to be different and the particle to PFU ratio artificially low.
Compensatory mutations for TM mutants
Deletion mutants yielding low amounts of infectious virus (DM379, DA385, DV386, and TM18C) were subjected to serial passage in an attempt to produce mutations, which may rescue virus infectivity (compensatory mutations). Other mutants yielding higher infectious virus titers were not subjected to serial passage as their titers were near wild type levels and the lack of selective pressure might result in the production of amino acid changes not related to the original defect. After three passages for DM379, DA385, and DV386 and five passages for TM18C an increase in infectious virus production was observed (Fig. 4) . After passage the single deletion mutants produced infectious virus at the same level as wt and the TM18C mutant infectious virus production was increased by approximately two orders of magnitude. RT/PCR followed by sequencing of both the E1 and E2 transmembrane domains of the revertants yielded no differences in the E1 transmembrane domain or the E2 endodomain (33 amino acid tail which interacts with capsid) but mutations compensating for the loss of virus growth (compensatory mutations) were found for all of these mutants in the E2 transmembrane domain (Fig. 5) . DM379 converted an alanine to a valine at position 372 and a serine was inserted adjacent to it. This compensatory mutation restored the wild type length (26 amino acids) to the transmembrane domain but did not restore M at 379. The DA385 compensatory mutation inserted a valine at the position of the alanine deletion, which also resulted in a wt length transmembrane domain. The DV386 compensatory mutation reverted to the original wt sequence and length, with the exception of a leucine being converted to a histidine for DV386#1 (Fig. 5) . These revertants suggest that wt length is important for normal virus growth in the C terminal half of the transmembrane domain.
After five passages, the TM18C mutant demonstrated a 100-fold increase in infectious virus production. The increase in virus production was accompanied by a four amino acid insertion, ACAC in the C terminal domain of the E2 transmembrane. The ACAC that was inserted contains the same nucleotide sequence as a repeat of the wt AC sequence preceding it (Fig. 5) . The TM18C compensatory mutation results in an increase from 18 to 22 amino acids spanning the transmembrane domain. When this compensatory mutation was compared to a previously described TM22 mutation , it was found that it produces approximately the same amount of infectious virus (10 6 pfu/ml) and the location of the remaining four amino acid deletion is in approximately the same location (Fig. 6) . This stresses the importance of the size and location of the deletion in the E2 transmembrane domain. No compensating mutations were found in the E2 endodomain or the transmembrane domain of the E1 glycoprotein for any of the mutants. This interesting result suggests that selective pressure favors restoring the Fig. 4 . Production of infectious virus by the TM25 and TM18 mutants before and after serial passage. Virus was passaged between three and five times for the mutants that produced lower titers (DM379, DA385, DV386 and TM18C). Infectious virus growth was rescued after serial passage. Solid bars represent virus growth before passage. Light bars represent virus growth after passage. After serial passage and an increase in infectious virus production, virus was isolated, purified, and RT/PCR followed by sequencing was performed. Mutants compensating for the increase in virus growth are underlined and highlighted in bold lettering. All mutants were examined in triplicate and all three trials resulted in identical sequences except for DV386. The resulting number of amino acids in the TM domain is noted on the right. No compensatory mutations were found in the E1 transmembrane domain or in the E2 tail domain that interacts with capsid.
deletion rather than altering a protein domain with which the mutated sequence is presumed to interact.
Discussion
The data presented herein demonstrate that a single deletion in the E2 transmembrane domain results in a significant loss of ability to produce infectious virus. It also shows that the effect of this deletion varies with its position in the TM sequence. The production of infectious virus is low for deletion mutations DM379, DA385, and DV386, located near the carboxyl terminus of the TM domain, while DA370, DV371, DA372, DS373, and DV376, located near the amino terminal end produce significantly more infectious virus. We also found that the inhibitory effect of a single insertion (FF) at the membrane interface is rescued when a compensating single amino acid deletion is placed in the middle of the transmembrane domain restoring the wild type number of amino acids in the E2 C terminal region (FF25). The relative importance of the two halves of the transmembrane domain was illustrated by the observation that the N terminal region of the E2 transmembrane domain could be deleted (TM18N) and the resulting mutant virus maintained wt growth, whereas deletion of the COOH terminal region (TM18C) resulted in a 10,000-fold decrease in infectious virus production.
Viral protein processing and transport appears normal as evidenced by SDS-PAGE analysis of purified virus released from cells. In addition, we have previously shown that protein processing and export from the ER by mutants containing deletions in the transmembrane domain is not affected until the deletion is larger than 12 amino acids (Hernandez et al., 2003) . The deletion mutants produced all band at wild type virus density indicating that they are similar in composition to wild type virus in that they contain a normal complement of protein, lipid, and RNA. SDS-PAGE of proteins in purified virus produced by the mutants indicated that they contained the same relative amounts of E1, E2 and capsid (Table 1 ). The process of assembly of these viruses is dependent upon a strict interaction of the three structural proteins in a 1:1:1 stoichiometric relationship. These data rule out the possibility that the reduced infectivity of the mutant viruses is the result of failure to assemble the normal amounts (240 copies of each) of virus proteins. Such an event would have, also, altered the buoyant density of the virus produced. Therefore, for all of the mutations produced, we have proposed a set of possible explanations to address the hypotheses stated in the introduction. These hypotheses were initially posed to account for the observed loss of infectious virus production produced by the original TM25 mutant :
Hypothesis (i). The observed phenotype of the original TM25 deletion could be a result of a single specific amino acid deletion at position 379 of E2. We found that the observed phenotype is not the result of the specific deletion of a methionine located at amino acid 379. DA385 and DV386 give similar reduced titers of approximately 10 6 pfu/ml. In addition the compensatory mutations identified after serial passage of DM379 resulted in a restoration of titer without replacing M379. These data suggest that deletion of a specific amino acid is not responsible for the TM 25 phenotype.
Hypothesis (ii). The angular location of the deletion on the face of the helix may account for the loss of infectivity (i.e., if the deletion is made 90 degrees, 180 degrees or another angle from a set point of reference). Fig. 2 reveals that the single amino acid deletions at positions DM379, DA385 and DV386 are located on the same side of the hydrophobic helix. These three deletions resulted in reduced virus growth, however DV371 is located on the same face of the hydrophobic helix and produces 100 times more infectious virus. This result suggests that the angular location on the face of the helix does not account for the loss of infectivity.
Hypothesis (iii). The location of the deletion vertically (i.e., closer to the lumenal side or closer to the cytoplasmic side of the membrane) may contribute to the observed phenotype. We found that single deletion mutants located closer to the lumenal face of the transmembrane had a less detrimental effect on virus infectivity than those located closer to the cytoplasmic face (Figs. 2 and 3) . This relationship was also true for the eight amino acid deletion (TM18) mutants where the TM18C mutant grew to a titer of 10 4 and the TM18N mutant grew to a titer of 10 9 pfu/ml (Figs. 2 and 3 ). These data suggest that the position of the deletion along the length of the hydrophobic helix plays a determinative role in the effect on virus assembly and infectivity. Interaction between E1 and E2 occurs above the luminal face of the transmembrane region (Anthony and Brown, 1991) . This could serve to anchor the proteins in a fixed position in the developing protein shell and all single deletions made in the transmembrane region may result in a one hundred degree rotation distal to the mutation (toward the COOH end). However, only single deletions in the C terminal half of the transmembrane domain result in reduced virus growth. This phenomenon may be explained by positioning the mutant E2 endodomain in an orientation unfavorable for correct interaction with the capsid protein. Deletions closer to the N terminus may allow for more degrees of freedom for E2 to interact properly with the capsid protein. Mutations located closer to the luminal face may have more flexibility to restore the wild type exit point of the protein from the cytoplasmic face of the transmembrane region.
The single deletion in the FF insertion mutant (FF25) mutant restores normal growth to the FF mutant. The FF25 mutant also restores the wild type number of amino acids in the C terminal region of E2. This result suggests the titer was restored because the length of the C terminal domain is critical for normal virus growth whereas the length in the N terminal domain is not critical. This is supported by the TM18N and TM18C comparison.
Hypothesis (iv). An interaction between the E1 and E2 transmembrane regions may be necessary for normal virus infectivity. This interaction may stabilize the E2 protein in a configuration where the E2 tail can most efficiently bind with the capsid protein. Fig. 2 shows that deletion mutations DM379, DA385, and DV386 are all located on one face of the helix and are all also located in the C terminal region of the E2 transmembrane domain. DM379, DA385 and DV386 all give reduced titers (10 6 ) and therefore may be involved in interactions with the transmembrane region of E1 near the cytoplasmic interface of the transmembrane domain. Strauss et al. (2002) demonstrated an interaction between E1 and E2 transmembrane domains using a chimeric virus composed of Ross River E1 and Sindbis virus E2. They identified a compensatory mutation in the center of the transmembrane domain of E2 (I380). In addition structural evidence from Mancini et al. (2000) shows that E1 and E2 protein densities in the transmembrane domain have the greatest degree of separation at the N terminal region and a minimal amount of separation halfway through the transmembrane domain. Zhang et al. also suggest that the E1 and E2 proteins are separated at the N terminal region of the transmembrane domain but come together in a coiled-coil structure toward the C terminal region of the transmembrane domain (Zhang et al., 2002) . These results suggest that the E1 and E2 transmembrane domains interact at a point halfway across the membrane bilayer and the association continues through the C terminal region of the transmembrane domain. These data may also explain why eight amino acids may be removed from the N terminal region of the E2 transmembrane domain with no loss of infectivity while deletion of eight amino acids in the C terminal domain results in a five log decrease of infectious virus production. These E1 -E2 associations described in the electron cryomicrographs of Mancini et al. (2000) may be necessary for virus stability and infectivity.
Only the FF insertion mutant seems to have an affect on virus particle assembly. The other mutants described in this study result in the production of approximately the same number of particles although the percentage of virus that is infectious vary greatly. The deletion mutants described in this study are not inhibited in their ability to transport membrane proteins to the cell surface as significant numbers of virus particles are produced. It has been demonstrated that association with PE2 is necessary for the transport of E1 to the cell surface (Carleton et al., 1997) . However, the E2 transmembrane domain deletions described here do not prevent this function. Mutations located closest to the cytoplasmic interface of the E2 transmembrane interface produce the lowest amount of infectious virus but have the highest particle/pfu ratio. This along with SDS-PAGE analysis and negative stains of purified virus particles indicates that proteins are being processed correctly, assembled into particles, and released, but the infectivity of these mutants is reduced by some other mechanism-likely by inhibiting cell entry.
After several passages the production of infectious virus by DM379, DA385, and DV386 was restored to wt levels and a 100-fold increase in infectious virus production was observed for the eight amino acid deletion (TM18C) mutant. Compensating mutations were found in the E2 transmembrane domain for all of these mutants (Fig. 5) . For all of the single deletion mutants a restoration to wt length in the TM domain accompanied restoration of wild type phenotype. Wt length in the TM domain may be necessary in the C terminal region of the transmembrane domain to produce a functional interaction with E1 or the capsid protein. The presence of a specific number of amino acids in this region may be necessary for correct protein -protein associations.
In addition to wt length, wt sequence is also restored for all the single deletion compensatory mutations to the C terminal half of the E2 transmembrane domain, except for DA385 where an A or V substitution occurred (Fig. 5) . This C terminal sequence may be necessary for proper interaction with E1 in the transmembrane domain. This is supported by the fact that TM18N grows to wt levels but TM18C only grows to a titer of 10 4 pfu/ml. Both of these mutants result in 18 amino acids in the transmembrane domain suggesting the sequence may be important for normal infectious virus production.
Compensatory mutations in TM18C resulted in a two-log increase in infectious virus production and the insertion of the amino acid sequence ACAC in the C terminal region of the transmembrane domain. The resulting 22 amino acid transmembrane domain deletion matched that of the original TM22 deletion mutant, produced by deletion cloning, (Fig. 6 ) and produced the same amount of infectious virus. This demonstrates that the location of the deletion is important for normal virus production. The insertion of the sequence ACAC in the C terminal region may indicate that it is necessary for normal virus growth. However, when the C at position 388 was converted to a serine from a wt parent no loss in infectious virus production was observed (data not shown). Schlesinger and others mutated each of these cysteines to alanines and found that there was no significant loss of virus infectivity (Ryan et al., 1998) suggesting the cysteines are not vital for normal virus growth. Collectively these results argue that transmembrane domains may serve functions other than to simply anchor the protein.
Data presented above suggest that deletion mutations in the TM domain of the E2 glycoprotein may inhibit events required for cell penetration since mutant viral proteins are processed correctly, assembled into particles, and released from the cell. We are presently examining the ability of the mutants to undergo the structural changes identified in the penetration process reported by Parades et al. (Paredes et al., 2004) .
Materials and methods
Cell culture and virus titration
Growth of baby hamster kidney cells (BHK-21) were described previously (Renz and Brown, 1976) . BHK cells were grown and maintained in minimal essential medium containing Earl's salts (Invitrogen, Carlsbad Calif.) supplemented with 10% fetal bovine serum (FBS) (Invitrogen), 5% tryptose phosphate broth, and 2 mM glutamine as described previously (Renz and Brown, 1976) . The virus vectors chosen for mutagenesis were Toto1101 (Rice et al., 1987) or Y420 which contains a substitution in E2 at position 420 changing a serine to a tyrosine. Y420, and has been described previously (Liu and Brown, 1993) . Titration of virus produced was performed using BHK-21 cell monolayers (Renz and Brown, 1976) . Virus was titered in triplicate.
TM mutants and reverse transcription (RT)/PCR analysis of mutant viruses
The TM mutants were made by QuikChange site-directed mutagenesis (Stratagene, La Jolla, CA) as described previously . Mutant viruses were named for the specific amino acid deleted from the amino terminus of the E2 protein. The PCR conditions were 95 -C for 1 min, 55 -C for 2 min, and 68 -C for 18 min. This cycle was repeated 15 times. After the desired mutations were made and confirmed by sequencing, they were subcloned into the Toto 1101 or Y420 vector using the BclI and BssHII (New England Biolabs, Beverly, MA) unique sites and linearized with Xho1. Infectious RNA was transcribed in vitro using SP6 RNA polymerase (New England Biolabs). To confirm that the desired deletions remained in the virus grown in cell culture, the RNA was extracted from the virus, reverse transcribed, and amplified by PCR (RT/PCR) .
In vitro transcription and RNA transfection
The mutant and wild-type cDNA constructs were prepared for transcription and transcribed in vitro as described previously (Hernandez et al., 2000) and . The RNA transcripts were electroporated into BHK or U4.4 cells. The electroporation was performed as described by Lilijestrom and Garoff (1991) . Virus was harvested 24 h posttransfection.
Virus growth, purification, quantitation and particle/PFU determination Virus growth in U4.4 and BHK cells and subsequent purification and quantitation were described previously . The highest multiplicity of infection possible for each of the mutant viruses was used for infection. An infection of the Toto1101 parent virus using a corresponding multiplicity of infection was also done (multiplicity of infection range was from 0.006 to 0.1). Virus was harvested from the cell supernatant after 24 h and was spun to equilibrium on 30 to 45% sucrose gradients in PBS-D buffer at 24,000 rpm in a Beckman SW-28 rotor overnight. 0.5 ml fractions were collected and titered . The amount of viral protein was determined by using the Micro BCA protein assay reagent kit (Pierce, Rockford, IL). 35 S labeled virus proteins were loaded on a 10.8% polyacrylamide gel to verify normal protein processing and to analyze the stoichiometric ratio of structural proteins produced. The resulting gels were exposed to X-ray film to produce exposures which did not, in any part of the gel, exceed the recording capacity (saturation density) of the film. The resulting protein profiles were scanned with an optical densitometer to obtain optical densities. For each mutant, the optical density of the protein E1 was arbitrarily set as 1 and other protein optical densities were presented relative to E1 in Table 1 .
The number of particles in a preparation of wild-type virus (SVHR) was determined under the electron microscope by the agar filtration protocol described by Kellenberger and Bitterli (1976) , and the particle count was correlated to the amount of protein as obtained by BCA. The total particle count was divided by the amount of infectious virus particles produced to determine the total number of particles per infectious particle (particle/pfu).
Serial passage of transmembrane mutants
Mutants yielding low infectious virus production were chosen for serial passage. Transfection of BHK cells with mutagenized RNA was performed as referenced above. Virus was harvested and titered on BHK-21 cells (Renz and Brown, 1976) . BHK monolayers were subsequently infected with harvested virus at an MOI of 1 or lower depending on the amount of infectious virus produced. Each passage was harvested after cytopathic effect was observed (24 -48h) and titered on BHK-21 cells. Plaques were picked, placed in 1 ml PBS-D containing 3% FBS and stored at 4 -C O/N. Plaques were flash frozen in N 2 and placed at À80 -C until use. Plaques were then used for a final round of infection. After 24h virus was harvested, extracted, and RT/PCR was performed as described earlier. Resulting PCR products were purified on a 4% agarose gel and were directly sequenced or subcloned using the pGem T-Vector System 1 (Promega, Madison, WI).
